IDEAYA Biosciences (IDYA) Revenue (2020 - 2026)
IDEAYA Biosciences (IDYA) recorded Revenue of $8.86 million in Q2 2026, up 35.0% from the prior quarter.
Analysis
IDEAYA Biosciences (IDYA) Revenue (2020 - 2026) Analysis & Trends
On a TTM basis, IDEAYA Biosciences' Revenue came in at $234.13 million as of Jun 30, 2026; for FY2025, it came in at $218.71 million.
- Annual Revenue has a five-year compound annual growth rate of 62.1% (FY2020 to FY2025).
- Across earlier years, Revenue came in at $7 million in FY2024 (-70.1%), $23.39 million in FY2023 (-54.1%), $50.93 million in FY2022 (+82.3%) and $27.94 million in FY2021 (+43.0%).
- Quarterly Revenue has ranged from $2.96 million in Q4 2021 to $207.83 million in Q3 2025 over the past five years.
- Peak year-over-year performance for Revenue in the last five years was growth of 230.9% in Q3 2022, against a decline of 72.9% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $6.56 million (Q1 2026), $10.88 million (Q4 2025) and $207.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 3.33 Bn |
| 10 | IDEAYA Biosciences | 3.65 Bn | 722.34 Mn | - | 8.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.86 Mn |
| Mar 31, 2026 | 6.56 Mn |
| Dec 31, 2025 | 10.88 Mn |
| Sep 30, 2025 | 207.83 Mn |
| Dec 31, 2024 | 7.00 Mn |
| Dec 31, 2023 | 3.92 Mn |
| Sep 30, 2023 | 8.04 Mn |
| Jun 30, 2023 | 3.54 Mn |
| Mar 31, 2023 | 7.88 Mn |
| Dec 31, 2022 | 4.02 Mn |
| Sep 30, 2022 | 29.70 Mn |
| Jun 30, 2022 | 5.85 Mn |
| Mar 31, 2022 | 11.36 Mn |
| Dec 31, 2021 | 2.96 Mn |
| Sep 30, 2021 | 8.98 Mn |
| Jun 30, 2021 | 8.76 Mn |
| Mar 31, 2021 | 7.25 Mn |
| Dec 31, 2020 | 10.57 Mn |
| Sep 30, 2020 | 8.97 Mn |
API Access
IDEAYA Biosciences Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=IDYA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "IDYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=IDYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();